Key result
Anticoagulant therapy after prosthetic heart valve replacement was associated with a lower rate of embolic episodes compared to no anticoagulants.
Why the study?
Does anticoagulant therapy reduce embolization in patients after prosthetic heart valve replacement?
Cohort (n=111)
Does anticoagulant therapy reduce embolization in patients after prosthetic heart valve replacement?
Anticoagulant therapy is highly effective in reducing thromboembolism from prosthetic heart valves, though careful monitoring is required to minimize hemorrhagic complications.
Answers are grounded in this paper and cite their sources.
Supports anticoagulation after prosthetic valve replacement; leaves open optimal regimens, monitoring, and bleeding risks in contemporary cohorts.
In this study, 111 patients, discharged from the hospital after prosthetic heart valve replacement, were followed for evidence of embolization. Ninety-three patients received anticoagulant therapy and five had embolic episodes (5%). In contrast, systemic emboli developed in eight of 18 patients (44%) who were not given anticoagulants. Documented hemorrhagic complications occurred nine times and there were two other suspicious incidents. Prothrombin times during the occurrence of these complications were known in ten instances and were prolonged above therapeutic levels in nine of these cases. There have been eleven late deaths (10%). Precise anticoagulation appears to be of value in reducing thromboembolism from prosthetic valves. However, careful control is necessary to minimize hemorrhagic complications.
No takes yet. Share an insight, caveat, or question.
Howard L. Gadboys (1967) conducted a cohort in Prosthetic heart valve replacement (n=111). Anticoagulant therapy vs. No anticoagulants was evaluated on Embolization. Anticoagulant therapy after prosthetic heart valve replacement was associated with a lower rate of embolic episodes compared to no anticoagulants.
Synapse has enriched 10 related papers. Consider them for comparative context: